Filing Details

Accession Number:
0001213900-19-021415
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-29 20:26:54
Reporting Period:
2019-10-25
Accepted Time:
2019-10-29 20:26:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1733413 Tff Pharmaceuticals Inc. TFFP Pharmaceutical Preparations (2834) 824344737
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1789490 G.l. Aaron Fletcher 2600 Via Fortuna, Suite 360
Austin TX 78746
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-25 2,000 $5.00 2,000 No 4 P Direct
Common Stock Acquisiton 2019-10-29 43,919 $0.00 45,919 No 4 C Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 C Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants Acquisiton 2019-10-29 43,794 $0.00 43,794 $5.00
Common Stock Series A Preferred Stock Disposition 2019-10-29 43,919 $0.00 43,919 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
179,693 2029-10-29 No 4 A Indirect
135,806 No 4 C Direct
Footnotes
  1. The shares of common stock purchased in the Issuer's initial public offering ("IPO").
  2. The shares of Series A preferred stock automatically converted into the Issuer's common stock upon the completion of the Issuer's IPO at the conversion price of $2.50 per share.
  3. 25% of the warrants vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years.
  4. Not Applicable.